Global Hemophilia Gene Therapy Market Research Report 2022

SKU ID : QYR-21014267 | Publishing Date : 06-Jun-2022 | No. of pages : 87

Request a free Sample

Detailed TOC of Global Hemophilia Gene Therapy Market Research Report 2022

1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Hemophilia Gene Therapy Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Hemophilia A
        1.2.3 Hemophilia B
    1.3 Market by Application
        1.3.1 Global Hemophilia Gene Therapy Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hemophilia A Gene Therapy
        1.3.3 Hemophilia B Gene Therapy
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Hemophilia Gene Therapy Market Perspective (2017-2028)
    2.2 Hemophilia Gene Therapy Growth Trends by Region
        2.2.1 Hemophilia Gene Therapy Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Hemophilia Gene Therapy Historic Market Size by Region (2017-2022)
        2.2.3 Hemophilia Gene Therapy Forecasted Market Size by Region (2023-2028)
    2.3 Hemophilia Gene Therapy Market Dynamics
        2.3.1 Hemophilia Gene Therapy Industry Trends
        2.3.2 Hemophilia Gene Therapy Market Drivers
        2.3.3 Hemophilia Gene Therapy Market Challenges
        2.3.4 Hemophilia Gene Therapy Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Hemophilia Gene Therapy Players by Revenue
        3.1.1 Global Top Hemophilia Gene Therapy Players by Revenue (2017-2022)
        3.1.2 Global Hemophilia Gene Therapy Revenue Market Share by Players (2017-2022)
    3.2 Global Hemophilia Gene Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Hemophilia Gene Therapy Revenue
    3.4 Global Hemophilia Gene Therapy Market Concentration Ratio
        3.4.1 Global Hemophilia Gene Therapy Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Hemophilia Gene Therapy Revenue in 2021
    3.5 Hemophilia Gene Therapy Key Players Head office and Area Served
    3.6 Key Players Hemophilia Gene Therapy Product Solution and Service
    3.7 Date of Enter into Hemophilia Gene Therapy Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Hemophilia Gene Therapy Breakdown Data by Type
    4.1 Global Hemophilia Gene Therapy Historic Market Size by Type (2017-2022)
    4.2 Global Hemophilia Gene Therapy Forecasted Market Size by Type (2023-2028)
5 Hemophilia Gene Therapy Breakdown Data by Application
    5.1 Global Hemophilia Gene Therapy Historic Market Size by Application (2017-2022)
    5.2 Global Hemophilia Gene Therapy Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Hemophilia Gene Therapy Market Size (2017-2028)
    6.2 North America Hemophilia Gene Therapy Market Size by Country (2017-2022)
    6.3 North America Hemophilia Gene Therapy Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Hemophilia Gene Therapy Market Size (2017-2028)
    7.2 Europe Hemophilia Gene Therapy Market Size by Country (2017-2022)
    7.3 Europe Hemophilia Gene Therapy Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Hemophilia Gene Therapy Market Size (2017-2028)
    8.2 Asia-Pacific Hemophilia Gene Therapy Market Size by Country (2017-2022)
    8.3 Asia-Pacific Hemophilia Gene Therapy Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Hemophilia Gene Therapy Market Size (2017-2028)
    9.2 Latin America Hemophilia Gene Therapy Market Size by Country (2017-2022)
    9.3 Latin America Hemophilia Gene Therapy Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Hemophilia Gene Therapy Market Size (2017-2028)
    10.2 Middle East & Africa Hemophilia Gene Therapy Market Size by Country (2017-2022)
    10.3 Middle East & Africa Hemophilia Gene Therapy Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Spark Therapeutics
        11.1.1 Spark Therapeutics Company Detail
        11.1.2 Spark Therapeutics Business Overview
        11.1.3 Spark Therapeutics Hemophilia Gene Therapy Introduction
        11.1.4 Spark Therapeutics Revenue in Hemophilia Gene Therapy Business (2017-2022)
        11.1.5 Spark Therapeutics Recent Development
    11.2 Ultragenyx
        11.2.1 Ultragenyx Company Detail
        11.2.2 Ultragenyx Business Overview
        11.2.3 Ultragenyx Hemophilia Gene Therapy Introduction
        11.2.4 Ultragenyx Revenue in Hemophilia Gene Therapy Business (2017-2022)
        11.2.5 Ultragenyx Recent Development
    11.3 Shire PLC
        11.3.1 Shire PLC Company Detail
        11.3.2 Shire PLC Business Overview
        11.3.3 Shire PLC Hemophilia Gene Therapy Introduction
        11.3.4 Shire PLC Revenue in Hemophilia Gene Therapy Business (2017-2022)
        11.3.5 Shire PLC Recent Development
    11.4 Sangamo Therapeutics
        11.4.1 Sangamo Therapeutics Company Detail
        11.4.2 Sangamo Therapeutics Business Overview
        11.4.3 Sangamo Therapeutics Hemophilia Gene Therapy Introduction
        11.4.4 Sangamo Therapeutics Revenue in Hemophilia Gene Therapy Business (2017-2022)
        11.4.5 Sangamo Therapeutics Recent Development
    11.5 Bioverativ
        11.5.1 Bioverativ Company Detail
        11.5.2 Bioverativ Business Overview
        11.5.3 Bioverativ Hemophilia Gene Therapy Introduction
        11.5.4 Bioverativ Revenue in Hemophilia Gene Therapy Business (2017-2022)
        11.5.5 Bioverativ Recent Development
    11.6 BioMarin
        11.6.1 BioMarin Company Detail
        11.6.2 BioMarin Business Overview
        11.6.3 BioMarin Hemophilia Gene Therapy Introduction
        11.6.4 BioMarin Revenue in Hemophilia Gene Therapy Business (2017-2022)
        11.6.5 BioMarin Recent Development
    11.7 uniQure
        11.7.1 uniQure Company Detail
        11.7.2 uniQure Business Overview
        11.7.3 uniQure Hemophilia Gene Therapy Introduction
        11.7.4 uniQure Revenue in Hemophilia Gene Therapy Business (2017-2022)
        11.7.5 uniQure Recent Development
    11.8 Freeline Therapeutics
        11.8.1 Freeline Therapeutics Company Detail
        11.8.2 Freeline Therapeutics Business Overview
        11.8.3 Freeline Therapeutics Hemophilia Gene Therapy Introduction
        11.8.4 Freeline Therapeutics Revenue in Hemophilia Gene Therapy Business (2017-2022)
        11.8.5 Freeline Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Figures, Tables and Charts Available in Global Hemophilia Gene Therapy Market Research Report 2022

List of Tables
    Table 1. Global Hemophilia Gene Therapy Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Hemophilia A
    Table 3. Key Players of Hemophilia B
    Table 4. Global Hemophilia Gene Therapy Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 5. Global Hemophilia Gene Therapy Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Hemophilia Gene Therapy Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global Hemophilia Gene Therapy Market Share by Region (2017-2022)
    Table 8. Global Hemophilia Gene Therapy Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global Hemophilia Gene Therapy Market Share by Region (2023-2028)
    Table 10. Hemophilia Gene Therapy Market Trends
    Table 11. Hemophilia Gene Therapy Market Drivers
    Table 12. Hemophilia Gene Therapy Market Challenges
    Table 13. Hemophilia Gene Therapy Market Restraints
    Table 14. Global Hemophilia Gene Therapy Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global Hemophilia Gene Therapy Market Share by Players (2017-2022)
    Table 16. Global Top Hemophilia Gene Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hemophilia Gene Therapy as of 2021)
    Table 17. Ranking of Global Top Hemophilia Gene Therapy Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by Hemophilia Gene Therapy Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Hemophilia Gene Therapy Product Solution and Service
    Table 21. Date of Enter into Hemophilia Gene Therapy Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Hemophilia Gene Therapy Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global Hemophilia Gene Therapy Revenue Market Share by Type (2017-2022)
    Table 25. Global Hemophilia Gene Therapy Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global Hemophilia Gene Therapy Revenue Market Share by Type (2023-2028)
    Table 27. Global Hemophilia Gene Therapy Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global Hemophilia Gene Therapy Revenue Market Share by Application (2017-2022)
    Table 29. Global Hemophilia Gene Therapy Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global Hemophilia Gene Therapy Revenue Market Share by Application (2023-2028)
    Table 31. North America Hemophilia Gene Therapy Market Size by Country (2017-2022) & (US$ Million)
    Table 32. North America Hemophilia Gene Therapy Market Size by Country (2023-2028) & (US$ Million)
    Table 33. Europe Hemophilia Gene Therapy Market Size by Country (2017-2022) & (US$ Million)
    Table 34. Europe Hemophilia Gene Therapy Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Asia-Pacific Hemophilia Gene Therapy Market Size by Region (2017-2022) & (US$ Million)
    Table 36. Asia-Pacific Hemophilia Gene Therapy Market Size by Region (2023-2028) & (US$ Million)
    Table 37. Latin America Hemophilia Gene Therapy Market Size by Country (2017-2022) & (US$ Million)
    Table 38. Latin America Hemophilia Gene Therapy Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Middle East & Africa Hemophilia Gene Therapy Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Middle East & Africa Hemophilia Gene Therapy Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Spark Therapeutics Company Detail
    Table 42. Spark Therapeutics Business Overview
    Table 43. Spark Therapeutics Hemophilia Gene Therapy Product
    Table 44. Spark Therapeutics Revenue in Hemophilia Gene Therapy Business (2017-2022) & (US$ Million)
    Table 45. Spark Therapeutics Recent Development
    Table 46. Ultragenyx Company Detail
    Table 47. Ultragenyx Business Overview
    Table 48. Ultragenyx Hemophilia Gene Therapy Product
    Table 49. Ultragenyx Revenue in Hemophilia Gene Therapy Business (2017-2022) & (US$ Million)
    Table 50. Ultragenyx Recent Development
    Table 51. Shire PLC Company Detail
    Table 52. Shire PLC Business Overview
    Table 53. Shire PLC Hemophilia Gene Therapy Product
    Table 54. Shire PLC Revenue in Hemophilia Gene Therapy Business (2017-2022) & (US$ Million)
    Table 55. Shire PLC Recent Development
    Table 56. Sangamo Therapeutics Company Detail
    Table 57. Sangamo Therapeutics Business Overview
    Table 58. Sangamo Therapeutics Hemophilia Gene Therapy Product
    Table 59. Sangamo Therapeutics Revenue in Hemophilia Gene Therapy Business (2017-2022) & (US$ Million)
    Table 60. Sangamo Therapeutics Recent Development
    Table 61. Bioverativ Company Detail
    Table 62. Bioverativ Business Overview
    Table 63. Bioverativ Hemophilia Gene Therapy Product
    Table 64. Bioverativ Revenue in Hemophilia Gene Therapy Business (2017-2022) & (US$ Million)
    Table 65. Bioverativ Recent Development
    Table 66. BioMarin Company Detail
    Table 67. BioMarin Business Overview
    Table 68. BioMarin Hemophilia Gene Therapy Product
    Table 69. BioMarin Revenue in Hemophilia Gene Therapy Business (2017-2022) & (US$ Million)
    Table 70. BioMarin Recent Development
    Table 71. uniQure Company Detail
    Table 72. uniQure Business Overview
    Table 73. uniQure Hemophilia Gene Therapy Product
    Table 74. uniQure Revenue in Hemophilia Gene Therapy Business (2017-2022) & (US$ Million)
    Table 75. uniQure Recent Development
    Table 76. Freeline Therapeutics Company Detail
    Table 77. Freeline Therapeutics Business Overview
    Table 78. Freeline Therapeutics Hemophilia Gene Therapy Product
    Table 79. Freeline Therapeutics Revenue in Hemophilia Gene Therapy Business (2017-2022) & (US$ Million)
    Table 80. Freeline Therapeutics Recent Development
    Table 81. Research Programs/Design for This Report
    Table 82. Key Data Information from Secondary Sources
    Table 83. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Hemophilia Gene Therapy Market Share by Type: 2021 VS 2028
    Figure 2. Hemophilia A Features
    Figure 3. Hemophilia B Features
    Figure 4. Global Hemophilia Gene Therapy Market Share by Application in 2021 & 2028
    Figure 5. Hemophilia A Gene Therapy Case Studies
    Figure 6. Hemophilia B Gene Therapy Case Studies
    Figure 7. Hemophilia Gene Therapy Report Years Considered
    Figure 8. Global Hemophilia Gene Therapy Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 9. Global Hemophilia Gene Therapy Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 10. Global Hemophilia Gene Therapy Market Share by Region: 2021 VS 2028
    Figure 11. Global Hemophilia Gene Therapy Market Share by Players in 2021
    Figure 12. Global Top Hemophilia Gene Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hemophilia Gene Therapy as of 2021)
    Figure 13. The Top 10 and 5 Players Market Share by Hemophilia Gene Therapy Revenue in 2021
    Figure 14. North America Hemophilia Gene Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 15. North America Hemophilia Gene Therapy Market Share by Country (2017-2028)
    Figure 16. United States Hemophilia Gene Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 17. Canada Hemophilia Gene Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 18. Europe Hemophilia Gene Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. Europe Hemophilia Gene Therapy Market Share by Country (2017-2028)
    Figure 20. Germany Hemophilia Gene Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. France Hemophilia Gene Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. U.K. Hemophilia Gene Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Italy Hemophilia Gene Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Russia Hemophilia Gene Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Nordic Countries Hemophilia Gene Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Asia-Pacific Hemophilia Gene Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Asia-Pacific Hemophilia Gene Therapy Market Share by Region (2017-2028)
    Figure 28. China Hemophilia Gene Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Japan Hemophilia Gene Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. South Korea Hemophilia Gene Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Southeast Asia Hemophilia Gene Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. India Hemophilia Gene Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Australia Hemophilia Gene Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Latin America Hemophilia Gene Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Latin America Hemophilia Gene Therapy Market Share by Country (2017-2028)
    Figure 36. Mexico Hemophilia Gene Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Brazil Hemophilia Gene Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Middle East & Africa Hemophilia Gene Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Middle East & Africa Hemophilia Gene Therapy Market Share by Country (2017-2028)
    Figure 40. Turkey Hemophilia Gene Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Saudi Arabia Hemophilia Gene Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Spark Therapeutics Revenue Growth Rate in Hemophilia Gene Therapy Business (2017-2022)
    Figure 43. Ultragenyx Revenue Growth Rate in Hemophilia Gene Therapy Business (2017-2022)
    Figure 44. Shire PLC Revenue Growth Rate in Hemophilia Gene Therapy Business (2017-2022)
    Figure 45. Sangamo Therapeutics Revenue Growth Rate in Hemophilia Gene Therapy Business (2017-2022)
    Figure 46. Bioverativ Revenue Growth Rate in Hemophilia Gene Therapy Business (2017-2022)
    Figure 47. BioMarin Revenue Growth Rate in Hemophilia Gene Therapy Business (2017-2022)
    Figure 48. uniQure Revenue Growth Rate in Hemophilia Gene Therapy Business (2017-2022)
    Figure 49. Freeline Therapeutics Revenue Growth Rate in Hemophilia Gene Therapy Business (2017-2022)
    Figure 50. Bottom-up and Top-down Approaches for This Report
    Figure 51. Data Triangulation
    Figure 52. Key Executives Interviewed